ABVC BioPharma, Inc. Restricted Cash, Current
ABVC BioPharma, Inc. (ABVC) had Restricted Cash, Current of $645.50 thousand as of 2025-12-31, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-12
- 2025-12-31: Restricted Cash, Current $645.50K.
- 2025-09-30: Restricted Cash, Current $661.84K.
- 2025-06-30: Restricted Cash, Current $688.08K.
- 2025-03-31: Restricted Cash, Current $607.36K.
USD
| Period end | Restricted Cash, Current |
|---|---|
| 2025-12-31 | $645.50K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $661.84K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $688.08K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $607.36K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $615.43K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $632.53K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $618.47K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $628.51K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $656.63K 10-K · filed 2025-04-15 |
TWD
| Period end | Restricted Cash, Current |
|---|---|
| 2025-12-31 | 20.30M TWD 10-Q · filed 2026-08-12 |
| 2025-09-30 | 20.20M TWD 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | 20.20M TWD 10-Q · filed 2025-08-13 |
| 2024-12-31 | 20.20M TWD 10-Q/A · filed 2026-03-03 |
| 2023-12-31 | 20.10M TWD 10-K · filed 2025-04-15 |